Fig. 1: Flowchart of patient disposition in the DE and LDAC cohorts.

AML, acute myeloid leukemia; LDAC, low-dose cytarabine; MDS, myelodysplastic syndrome; No., Number; R/R, relapsed/refractory.

AML, acute myeloid leukemia; LDAC, low-dose cytarabine; MDS, myelodysplastic syndrome; No., Number; R/R, relapsed/refractory.